The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Industry, Sector and Symbol
Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
Phone302-773-1000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$6.18 billion
Profitability
Miscellaneous
Employees7,000
OptionableOptionable
Chemours (NYSE:CC) Frequently Asked Questions
What is Chemours' stock symbol?
Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."
How often does Chemours pay dividends? What is the dividend yield for Chemours?
Chemours announced a quarterly dividend on Tuesday, October 30th. Stockholders of record on Friday, November 16th will be given a dividend of $0.25 per share on Friday, December 14th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.93%. The ex-dividend date is Thursday, November 15th. View Chemours' Dividend History.
How will Chemours' stock buyback program work?
Chemours declared that its Board of Directors has approved a share repurchase plan on Monday, December 4th 2017, which permits the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy shares of its stock through open market purchases. Stock buyback plans are often an indication that the company's management believes its shares are undervalued.
How were Chemours' earnings last quarter?
Chemours Co (NYSE:CC) posted its quarterly earnings data on Thursday, November, 1st. The specialty chemicals company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.07. The specialty chemicals company earned $1.63 billion during the quarter, compared to analysts' expectations of $1.71 billion. Chemours had a return on equity of 106.98% and a net margin of 16.02%. Chemours's quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.12 earnings per share. View Chemours' Earnings History.
When is Chemours' next earnings date?
What price target have analysts set for CC?
9 analysts have issued 12-month target prices for Chemours' shares. Their forecasts range from $38.00 to $60.00. On average, they expect Chemours' stock price to reach $48.1250 in the next year. This suggests a possible upside of 41.0% from the stock's current price. View Analyst Price Targets for Chemours.
What is the consensus analysts' recommendation for Chemours?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemours.
Has Chemours been receiving favorable news coverage?
Media coverage about CC stock has been trending neutral recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chemours earned a news sentiment score of 0.5 on InfoTrie's scale. They also assigned media stories about the specialty chemicals company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the near future.
Who are some of Chemours' key competitors?
Some companies that are related to Chemours include Koninklijke DSM (RDSMY), ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), KURARAY CO LTD/ADR (KURRY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), Ingevity (NGVT), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP) and Innospec (IOSP).
Who are Chemours' key executives?
Chemours' management team includes the folowing people:
- Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)
- Mr. Mark E. Newman, Sr. VP & CFO (Age 56)
- Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)
- Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)
- Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55)
Who are Chemours' major shareholders?
Chemours' stock is owned by many different of retail and institutional investors. Top institutional investors include Retirement Systems of Alabama (0.19%), DNB Asset Management AS (0.09%), Gateway Investment Advisers LLC (0.05%), Louisiana State Employees Retirement System (0.03%), Highland Capital Management LLC (0.02%) and Meeder Asset Management Inc. (0.01%). Company insiders that own Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for Chemours.
Which major investors are selling Chemours stock?
CC stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Retirement Systems of Alabama, Meeder Asset Management Inc., Louisiana State Employees Retirement System, Oakbrook Investments LLC and State of Alaska Department of Revenue. Company insiders that have sold Chemours company stock in the last year include Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours.
Which major investors are buying Chemours stock?
CC stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Highland Capital Management LLC, Gateway Investment Advisers LLC and Bourgeon Capital Management LLC. View Insider Buying and Selling for Chemours.
How do I buy shares of Chemours?
Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Chemours' stock price today?
One share of CC stock can currently be purchased for approximately $34.12.
How big of a company is Chemours?
Chemours has a market capitalization of $5.59 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. Chemours employs 7,000 workers across the globe.
What is Chemours' official website?
How can I contact Chemours?
Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]
MarketBeat Community Rating for Chemours (NYSE CC)
MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.
